Research programme: cell therapies - LIfT Biosciences
Alternative Names: AMR/Other - LIfT BiosciencesLatest Information Update: 19 Jul 2023
At a glance
- Originator LIfT Biosciences
- Class Cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Infections; Unspecified
Most Recent Events
- 19 Jul 2023 Early research in Infections in United Kingdom (Parenteral) before July 2023 (LIfT Biosciences pipeline, July 2023)
- 19 Jul 2023 Early research in Unspecified in United Kingdom (Parenteral) before July 2023 (LIfT Biosciences pipeline, July 2023)